DBV Technologies | Lånekapital



Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
DBV Technologies USD 0 0 2024-09
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Incyte USD 33.54M 5.32M 2024-12
Insmed USD 1.13B 147.77M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12



DBV Technologies Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.